In addition, we examined the enrichment of repressive histone marks H3K9me2 and H3K27me2 on the promoter of DGAT2 in KDM7A-overexpressing AML12 cells and assessed the development of hepatic steatosis in vivo in KDM7A-overexpressing mice. This evidence concerns the gene DGAT2 and fatty liver disease.